Uterine Cancer Study Act of 2025

United States119th CongressS-2285Senate
Updated: Jul 15, 2025

Summary

This bill mandates the Secretary of Health and Human Services to conduct a comprehensive study on the link between chemical hair straighteners and uterine cancer. This study will be carried out in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health. The study is specifically tasked with investigating the increased incidence of uterine cancer among women of color , while also considering impacts on all racial and ethnic groups. It requires a review of existing research, disaggregation of results based on product components like dyes or perms, and an evaluation of whether the Food and Drug Administration should implement additional testing requirements for manufacturers of these products. The Secretary must submit a methodology description within 45 days, commence the study within 180 days, and complete the study and submit a report to Congress within two years of the Act's enactment.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-4396: Uterine Cancer Study Act of 2025

Introduced in House

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

  2. Introduced in Senate

All available records shown.